JP Morgan Healthcare Conference, Day Three: NanoString, BD, Bio-Rad, Cepheid, Quidel, GenMark, PacBio, Adaptive Biotechnologies | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference continued here Wednesday with presentations from several life science tools and diagnostic firms.

The following are capsules from the presentations and breakout sessions of Nanostring, Becton Dickinson, Bio-Rad, Cepheid, Quidel, GenMark, Pacific Biosciences, and Adaptive Biotechnologies. Coverage of Danaher's presentation, in which the company discussed its acquisition plans, is available here.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.